Solaiman Shokur2019 - now : Senior Scientist, Translational neuroengineering Laboratory, EPFL(Geneva)
Team leader: CHRONOS project, a multi-center European project that aims at developing the first chronically implanted prosthetic hand for transradial amputee patients with bidirectional communication capabilities. NCCR Robotics: Bi-directional control of supernumerary limbs.2014-2019: Research Coordinator, AASDAP (São Paulo, Brazil) Responsible for both the scientific production and the clinical protocol at the AASDAP neurorehabilitation laboratory.
2013-2014: Postdoctoral associate, Walk again project, Insituto Santos Dumond. (Natal, RN, Brazil)Head of the engineering team in charge of the system integration. 2010-2012: Visiting scientist, Nicolelis Lab (Duke University).
Development and validation of a virtual-reality based brain-machine interface for rhesus monkeys.
2007 – 2010: Teaching assistant, Laboratory of Robotics Systems (EPFL)
Anja SkrivervikAnja Skrivervik obtained her electrical engineering degree from Ecole Polytechnique Fédérale de Lausanne in 1986, and her PhD from the same institution in 1992, for which she received the Latsis award. After a stay at the University of Rennes as an invited Research Fellow and two years in the industry, she returned part time to EPFL as an Assistant Professor in 1996, and is now a Professeur Titulaire at this institution, where she is the head of the Microwave and Antenna Group. Her research activities include electrically small antennas, antennas in biological media, periodic structures, reflect- and tranmitarrays, and numerical techniques for electromagnetics. She is author or co-author of more than 200 peer reviewed scientific publications. Her teaching activities include courses on microwaves and antennas, and she has course at Bachelor, Master and PhD levels. She was director of the EE section form 1996-2000, and is currently the director of the EE doctoral school at EPFL.
She is very active in European collaboration and European projects. She was the chairperson of the Swiss URSI until 2012, is a Board member of the European School on Antennas and is frequently requested to review research programs and centers in Europe. She is a member of the board of directors of the European Association on Antennas and Propagation (EurAAP) since 2017.
Cathrin BriskenCathrin Brisken, MD, PhD, is Associate Professor of Life Sciences at the Swiss Federal Institute of Technology Lausanne (EPFL). Dr. Brisken is internationally recognized for her work on endocrine control of mammary gland development and breast carcinogenesis.
Dr. Brisken received her MD and her PhD degree in Biophysics from the Georg August University of Göttingen, Germany. She completed her postdoctoral work in cancer biology with Dr. R.A. Weinberg at the Whitehead Institute of Biomedical Research in Cambridge, MA, USA. She previously held appointments at the Cancer Center of the Massachusetts General Hospital, Harvard Medical School, Boston and the Swiss Institute for Experimental Cancer Research (ISREC).
Research in Dr. Brisken’s laboratory focuses on the cellular and molecular underpinnings of estrogen and progesterone receptor signaling in the breast and the respective roles of these hormones and hormonally active compounds in carcinogenesis. The aim is to understand how recurrent exposures to endogenous and exogenous hormones contribute to breast carcinogenesis in order to better prevent and treat the disease. The laboratory has pioneered in vivo approaches to genetically dissect the role of the reproductive hormones in driving mouse mammary gland development and shown how they control intercellular communication. Dr. Brisken’s group has developed ex vivo and humanized mouse models using patient samples to study hormone action in human tissues in normal settings and during disease progression.
Dr. Brisken is member of the International Breast Cancer Study Group (IBCSG) Biological Protocol Working Group. She served as Dean of EPFL Doctoral School (more than 2000 PhD students in 18 PhD programs), as member of the Hinterzartener Kreis, the oncology think-tank associated with the German Science Foundation, and numerous Swiss, European, and AACR committees. She co-founded the International Cancer Prevention Institute.
Maria Giulia PretiMaria Giulia Preti received her Ph.D. in Bioengineering at Politecnico di Milano (Milan, Italy) in 2013, after her M. Sc. (2009) and B. Sc. (2007) in Biomedical Engineering, as well at Politecnico di Milano. During her Ph.D., mentored by Prof. Giuseppe Baselli, she focused on advanced techniques of brain magnetic resonance imaging, in particular she developed a method of groupwise fMRI-guided tractography, that revealed to be useful in the in-vivo investigation of the pathophysiological changes across the evolution of Alzheimers disease. For this project, she had been collaborating full-time with the hospital Fondazione Don Gnocchi in Milan (Magnetic Resonance Laboratory). In 2011, she was awarded a Progetto Rocca fellowship from MIT-Italy and spent a visiting research period at the MIT and Harvard Medical School (Boston, USA), under the supervision of Prof. Nikos Makris, where she could focus on the anatomical study of specific neruonal bundles.
She has joined Prof. Van De Ville group at EPFL as a post-doc in 2013. Her current research aims at understanding the connections between brain functionality and brain microscopic anatomy by using advanced techniques of Magnetic Resonance Imaging. In particular, she is working on functional MRI, functional connectivity, diffusion tensor imaging and tractography, integration of MRI with other techniques (e.g. EEG), and the application of these methods to several clinical contexts, e.g., epilepsy, Alzheimer's disease and mild cognitive impairment, multiple sclerosis, attention deficit hyperactivity disorder.
